Published in Health and Medicine Week, October 27th, 2003
"As a leader in the development of products with global health impact in the area of HIV, Biosyn is extremely pleased to receive this funding commitment from IPM," said Anne-Marie Corner, president and CEO of Biosyn. "These funds, combined with the previously announced $10 million grant from the National Institutes of Health, will help to ensure the rapid advancement of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week